Organogenesis Holdings Inc. ORGO Temporary Equity, Accretion to Redemption Value, Adjustment
Temporary Equity, Accretion to Redemption Value, Adjustment at other companies
Other financials
Where this comes from
Reported directly by Organogenesis Holdings Inc. in its filing.
Tagged under the XBRL concept us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment.
The official record: Organogenesis Holdings Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Organogenesis Holdings Inc.'s temporary equity, accretion to redemption value, adjustment.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Organogenesis Holdings Inc.'s temporary equity, accretion to redemption value, adjustment?
- Organogenesis Holdings Inc. (ORGO) reported temporary equity, accretion to redemption value, adjustment of $159K in Q1 2026.
- How has Organogenesis Holdings Inc.'s temporary equity, accretion to redemption value, adjustment changed year-over-year?
- Organogenesis Holdings Inc.'s temporary equity, accretion to redemption value, adjustment increased by 31.4% year-over-year, from $121K to $159K.
- What does temporary equity, accretion to redemption value, adjustment mean?
- This represents the periodic adjustment to the carrying amount of redeemable equity instruments to reflect their redemption value at the expected settlement date. It ensures that the balance sheet reflects the ultimate obligation to shareholders for these specific equity classes. This adjustment is essential for understanding the true economic cost of capital structures involving redeemable securities.